144 related articles for article (PubMed ID: 21330833)
21. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
22. Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.
Wang YC; Lee HS; Chen SK; Yang SC; Chen CY
J Cancer Res Clin Oncol; 1998; 124(9):517-22. PubMed ID: 9808427
[TBL] [Abstract][Full Text] [Related]
23. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.
Pelosi G; Scarpa A; Manzotti M; Veronesi G; Spaggiari L; Fraggetta F; Nappi O; Benini E; Pasini F; Antonello D; Iannucci A; Maisonneuve P; Viale G
Mod Pathol; 2004 May; 17(5):538-46. PubMed ID: 14990969
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
25. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract][Full Text] [Related]
26. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
Zhang G; Sun Y; Wang M
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
[TBL] [Abstract][Full Text] [Related]
27. BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
Kumar R; Angelini S; Czene K; Sauroja I; Hahka-Kemppinen M; Pyrhönen S; Hemminki K
Clin Cancer Res; 2003 Aug; 9(9):3362-8. PubMed ID: 12960123
[TBL] [Abstract][Full Text] [Related]
28. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
29. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
30. Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer.
Murugan AK; Hong NT; Cuc TT; Hung NC; Munirajan AK; Ikeda MA; Tsuchida N
Oral Oncol; 2009 Oct; 45(10):e161-6. PubMed ID: 19628422
[TBL] [Abstract][Full Text] [Related]
31. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
32. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
33. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
Keohavong P; DeMichele MA; Melacrinos AC; Landreneau RJ; Weyant RJ; Siegfried JM
Clin Cancer Res; 1996 Feb; 2(2):411-8. PubMed ID: 9816185
[TBL] [Abstract][Full Text] [Related]
34. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
[TBL] [Abstract][Full Text] [Related]
35. High incidence of point mutation in K-ras codon 12 in carcinoma of the fallopian tube.
Mizuuchi H; Mori Y; Sato K; Kamiya H; Okamura N; Nasim S; Garrett CT; Kudo R
Cancer; 1995 Jul; 76(1):86-90. PubMed ID: 8630881
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer.
Kazmi HR; Chandra A; Nigam J; Noushif M; Parmar D; Gupta V
Dig Surg; 2013; 30(3):233-9. PubMed ID: 23838952
[TBL] [Abstract][Full Text] [Related]
38. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer.
Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN
Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179
[TBL] [Abstract][Full Text] [Related]
39. ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.
Casson AG; Wilson SM; McCart JA; O'Malley FP; Ozcelik H; Tsao MS; Chambers AF
Int J Cancer; 1997 Sep; 72(5):739-45. PubMed ID: 9311587
[TBL] [Abstract][Full Text] [Related]
40. Frequent ras gene mutations in squamous cell cervical cancer.
Wong YF; Chung TK; Cheung TH; Lam SK; Xu YG; Chang AM
Cancer Lett; 1995 Aug; 95(1-2):29-32. PubMed ID: 7656240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
